Overall ManagementTumors of the Skull Base


ECCO 12 - the European Cancer Conference Copenhagen, Denmark, 21-25 September 2003. Abstract No. 137 (Clinical Study)
European Journal of Cancer Supplements; Vol. 1, No. 5, September 2003, page S45


Meeting Abstract

Advanced tumors of the skull base. Diagnostic, clinical and therapeutic features

A.M. Mudunov1, E.G. Matyakin1, O.M. Meluzova2

1Blokhins Cancer Research Centre, Upper Aerodigestive Tract Tumors, Moscow, Russian Federation; 2Blokhins Cancer Research Centre, X-Ray Diagnostic Methods, Moscow, Russian Federation

Introduction. Tumors of the skull base are one of the most difficult nosological forms among others in head and neck due to the complex topography, absence of clear clinical picture and therapeutic tactic, difficulties of surgical intervention owing to the combined lesion of several anatomic zones and consequently low survival rate and disease-free follow-up.

Material and methods. 320 patients with various tumors of the skull base were treated at our clinic for the period within 1980-2003. 
146 (45.6%) pts out of them with various malignant tumors of paranasal sinuses and nose cavity (including 12 (3.7%) with esthesioneuroblastoma), 167 (52.2%) with the soft-tissue tumors of parapharyngeal localization, 4 (1/2%) primary tumors of the orbit, 3 (1%) advanced skin cancer spreading into the skull base. 
Cure tactic depended on histologic type, tumor spreading and localization. 
Main diagnostic procedures were CT, MRI scanning, ultrasound, in some cases angyography, endoscopy, aspiration biopsy and postoperative histology.

Results. 18 (5.6%) pts mainly with mesenchymal tumors and primary skull base cancer had chemoradiotherapy as the first step procedure with subsequent surgery. 
36 (11.2%) pts had palliative chemoradiotherapy with 27.7% complete clinical response. 
Combined treatment modality (radiotherapy + surgery) performed in 48 (15%) cases of epithelial cancers. 
44 (13.7%) pts had palliative radiotherapy with 6.8% complete clinical response. 
223 patients had an operation. 
Extended surgery performed in 71 (31.8%) cases with combined resections of maxilla at one or both sites, orbit, ethmoidal cells, walls of frontal and sphenoid sinuses, dura mater. 
27 (8.4%) pts had intracranial tumor spreading into anterior, middle and/or posterior cranial fossa. 
In these cases combined craniofacial approach performed for radical surgery with subsequent plastic reconstruction of the dura defect by pericranial or myofascial flap. 
Liquorrhea developed in 2 (7.4%) cases. 
An external neck approach was quiet enough for total removal of parapharyngeal tumors (160 pts) located basically in the limits of infratemporal fossa. 
27 (8.4%) pts with advanced primary tumors had different treatment failures such as local recurrence or distant metastasis.

Conclusions. Preoperative chemoradiotherapy in advanced non-epithelial tumors of the skull base allows to achieve significant regress of the primary site and to increase resectability. 
Application of CT and MRI allows in most cases detect correct diagnosis, especially in benign tumors, estimate tumor spreading and connections to the main anatomic formations of the head and neck (blood vessels, nervous branches, brain and spinal cord), plane further surgery volume and adequate cure. 
Intracranial tumor spreading required combined craniofacial approach with the purpose for radical surgery.

© 2003 Elsevier Ltd. All rights reserved.

Source: http://ex2.excerptamedica.com/ciw-03ecco/abstracts/index.cfm?fuseaction=abs.prn&abstractID=137



 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP